These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38842132)

  • 1. Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alshammari MS; Alexiou A; Papadakis M; Bahaa MM; Batiha GE
    J Cell Mol Med; 2024 Jun; 28(11):e18412. PubMed ID: 38842132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CDK5/P25 formation/inhibition in neurodegeneration.
    Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
    Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro.
    Czapski GA; Gąssowska M; Wilkaniec A; Cieślik M; Adamczyk A
    FEBS Lett; 2013 Sep; 587(18):3135-41. PubMed ID: 23954626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
    J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease.
    Alvira D; Ferrer I; Gutierrez-Cuesta J; Garcia-Castro B; Pallàs M; Camins A
    Parkinsonism Relat Disord; 2008; 14(4):309-13. PubMed ID: 17977053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-5a Promotes Neural Development and Differentiation by Regulating CDK5 via Ca2+/Calpain Pathway.
    Shu Y; Xiang M; Zhang P; Qi G; He F; Zhang Q; Zhang Z; Lv Z; Peng X; Cai H; Tian B
    Cell Physiol Biochem; 2018; 51(6):2604-2615. PubMed ID: 30562750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
    Schmid G; Strosznajder JB; Wesierska-Gadek J
    Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
    Chen J; Wang ZF
    Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
    Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
    Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological functions of CDK5 and potential CDK5 targeted clinical treatments.
    Shupp A; Casimiro MC; Pestell RG
    Oncotarget; 2017 Mar; 8(10):17373-17382. PubMed ID: 28077789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK4 and CDK5 Inhibition Have Comparable Mild Hypothermia Effects in Preventing Drp1-Dependent Mitochondrial Fission and Neuron Death Induced by MPP
    Yang SH; Huang CY; Hsieh CY; Chuang JI
    Mol Neurobiol; 2020 Oct; 57(10):4090-4105. PubMed ID: 32666227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.
    Odemuyiwa SO; Ilarraza R; Davoine F; Logan MR; Shayeganpour A; Wu Y; Majaesic C; Adamko DJ; Moqbel R; Lacy P
    Immunology; 2015 Apr; 144(4):641-8. PubMed ID: 25346443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.
    Minegishi S; Asada A; Miyauchi S; Fuchigami T; Saito T; Hisanaga S
    Biochemistry; 2010 Jul; 49(26):5482-93. PubMed ID: 20518484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.
    Patzke H; Tsai LH
    J Biol Chem; 2002 Mar; 277(10):8054-60. PubMed ID: 11784720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.